Ceryvyn Therapeutics Limited
CYVNY
$0.02
-$0.01-35.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.39% | -102.91% | 0.32% | 793.97% | -2.12% |
| Total Depreciation and Amortization | -- | -- | -- | -- | 2.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.39% | 103.08% | -0.32% | -479.77% | -2.12% |
| Change in Net Operating Assets | -0.39% | -- | -- | -- | -2.12% |
| Cash from Operations | -0.39% | 72.71% | -0.32% | 92.38% | -2.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 0.00% | -56,056.36% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00% | -0.32% | -207.60% | -2.12% |
| Foreign Exchange rate Adjustments | -0.42% | -2,884.06% | 0.00% | -99.51% | 2.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.39% | 91.93% | -0.32% | 69.97% | -2.12% |